Organization
ABX Advanced Biochemical Compounds
2 clinical trials
Clinical trial
Phase III Study of [18F]PSMA-1007 Positron Emission Tomography for the Detection of Prostate Cancer Lesions in Patients With Biochemical Recurrence After Previous Definitive Treatment for Localized Prostate CancerStatus: Active (not recruiting), Estimated PCD: 2023-06-23
Clinical trial
Prospective, Multi-Center Study to Assess the Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed High-Risk or Very-High-Risk Prostate CancerStatus: Not yet recruiting, Estimated PCD: 2025-04-01